AzTrials
AzTrials

Excessive WorryNCT02638792

Internet-Based Exposure Therapy Vs. Stress-Management Training for Worry

A study testing Internet-based exposure therapy (I-ET) and Internet-based stress management therapy in people with Excessive Worry, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to examine if an internet-based exposure therapy is more effective in reducing excessive worry amongst patients who suffer from this problem than is internet-based stress management training. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Excessive Worry
What is being tested?
Internet-based exposure therapy (I-ET) and Internet-based stress management therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
311 participants
Where
1 siteSweden
Study dates
Dec 2015to May 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Outpatients
  • ≥ 18 years
  • Situated in Sweden
  • Informed consent
  • PSWQ score more than 56 points

Who cannot join

  • Substance dependence during the last six months
  • Post traumatic stress disorder, bipolar disorder or psychosis
  • Symptoms better explained by axis 2 diagnosis (e.g. autism or borderline personality disorder)
  • MADRS-S score above 25 points
  • Psychotropic medication changes within two months prior to treatment that could affect target symptoms.
  • Received exposure based CBT for pathological worry the last 2 years.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Karolinska Intitutet

    Stockholm, 17177

Other trials in Sweden

About this study

Official title: Internet-Based Exposure Therapy Vs. Stress-Management Training for Worry: A Randomized Controlled Trial

The purpose of this study is to examine if an internet-based exposure therapy is more effective in reducing excessive worry amongst patients who suffer from this problem than is internet-based stress management training.

Read the detailed description

Trial Objectives: Primary objective is to investigate whether an Internet-based exposure therapy can reduce the degree of excessive worry to a significantly greater extent than Internet-based stress-management training. The secondary objective is to a) investigate the cost-effectiveness of this treatment b) to study if any variables could moderate/mediate the treatment outcome, c) and to investigate the importance of sudden gains for the treatment outcome

Trial Design: Randomized controlled trial with an active control and a waitlist control, who also will recieve treatment after the first group has finished.

Duration: Ten weeks

Primary Endpoint:

Difference in worry symptoms between the treatment groups at week 10. Long term follow-up is also investigated (baseline to 4-months after treatment completion and baseline to 12-months after treatment completion).

Efficacy Parameters: Penn State Worry Questionnaire (PSWQ)

Safety Parameters: Adverse Events is assessed via the internet.

Description of Trial Subjects: Patients > 18 years old with a PSWQ score more than 56 points

Number of Subjects: 300

Conditions
Excessive Worry
Being tested
Internet-based exposure therapy (I-ET), Internet-based stress management therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet-based exposure therapy (I-ET)Behavioural

    The internet-based exposure therapy (I-ET) group receives a ten-week Internet-based CBT treatment, which is an extended version of the self-help book "Sluta älta och grubbla med kognitiv beteendeterapi" (How to quit worrying and ruminating with Cognitive behavior therapy) by licensed psychologist Olle Wadström (2007). The main focus of the book is to expose to the frightening word/image and refrain from using neutralizing thoughts. This is supposed to lead to the extinction of upsetting words/images.

  • Internet-based stress management therapyBehavioural

    The I-SMT group receives a ten-week Internet-based CBT treatment focused on stress and how to manage stressful situations. This protocol is based on current evidence based recommendations for worry and has shown to be effective when delivered via the internet for irritable bowel syndrome and hypochondric worries.

Study groups in NCT02638792
Study groupRoleWhat they receive
Internet-based exposure therapyExperimentalThe internet-based exposure therapy (I-ET) group receives a ten-week Internet-based CBT treatment, which is an extended version of the self-help book "Sluta älta och grubbla med kognitiv beteendeterapi" (How to quit worrying and ruminating with Cognitive behavior therapy) by licensed psychologist Olle Wadström (2007). The main focus of the book is to expose to the frightening word/image and refrain from using neutralizing thoughts. This is supposed to lead to the extinction of upsetting words/images.
Receives: Behavioral: Internet-based exposure therapy (I-ET)
Internet-based stress management therapyActive comparatorThe I-SMT group receives a ten-week Internet-based CBT treatment focused on stress and how to manage stressful situations. This protocol is based on current evidence based recommendations for worry and has shown to be effective when delivered via the internet for irritable bowel syndrome and hypochondric worries.
Receives: Behavioral: Internet-based stress management therapy
WaitlistNo interventionWhen the active treatment groups have finished treatment (W11), the WL group will be able to start active treatment and be assessed at post-treatment, and 4, 12 months later using the same questionnaires as the treatment group. The participants will be able to choose which treatment they receive i.e. no randomization.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Penn State Worry Questionnaire (PSWQ)

    Change in worry from baseline to Week 10 and at 4- and 12 months after treatment has ended.

    Measured: week 0, week 10 (weekly measurements), at 4 months follow up, 12 months follow up.

Secondary outcomes (10)
  1. Montgomery Åsberg Depression Rating Scale (MADRS-S)

    Change in depression from baseline to Week 10 and at 4- and 12 months after treatment has ended.

    Measured: Week 0, Week 10, 4 and 12 months follow-up

  2. Euroqol, EQ-5D

    Change in general health from baseline to Week 10 and at 4- and 12 months after treatment has ended

    Measured: Week 0, Week 10, 4 and 12 months follow-up

  3. Cognitive Avoidance Questionnaire (CAQ)

    Change in cognitive avoidance from baseline to Week 10, at 4- and 12 after treatment has ended, and weekly during treatment

    Measured: Week 0, Week 10, at 4 and 12 months follow up and weekly during treatment

  4. Intolerance of uncertainty scale

    Change in thought control efforts from baseline to Week 10, at 4- and 12 months after treatment has ended, and weekly during treatment

    Measured: Week 0, Week 10, at 4 and 12 months follow-up, and weekly during treatment

  5. Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry (TIC-P)

    Change in economic costs from baseline to Week 10 and at 4- and 12 months after treatment has ended

    Measured: Week 0, Week 10, 4 and 12 months follow-up

  6. Brunnsviken Quality of Life Questionnaire (BBQ)

    Change in self-perceived quality of life from baseline to week 10 and at 4 and 12 months after treatment has ended

    Measured: Week 0, Week 10, 4 and 12 months follow-up

  7. Thought supression subscale of the Cognitive Avoidance Questionnaire (CAQ)

    Weekly change in thought supression from baseline to Week 10

    Measured: Week 0 - Week 10 (weekly measurements)

  8. The self-regulation subscale of the Multidimensional Assessment of Interoceptive Awareness

    Weekly change in self-regulation from baseline to Week 10

    Measured: Week 0 - Week 10 (weekly measurements)

  9. Patient Health Questionnaire-2

    Weekly change in depressive symptom from baseline to Week 10

    Measured: Week 0 - Week 10 (weekly measurements)

  10. Adverse Events

    Number of adverse events from baseline to Week 10 and at 4 and 12 months

    Measured: Week 3, week 8, week 10, 4 and 12 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2015 (estimated)
  2. Study startDec 2015
  3. Primary completionMay 2016
  4. Study completionMay 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
311 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02638792
Sponsor's protocol ID
REPN 2015/1698-31/1
Status last verified
Nov 2017
First submitted
19 Dec 2015
Last updated
28 Nov 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Internet-based exposure therapy (I-ET) and Internet-based stress management therapy in people with Excessive Worry, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Penn State Worry Questionnaire (PSWQ) (time frame: week 0, week 10 (weekly measurements), at 4 months follow up, 12 months follow up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in